Sustainable #APIdevelopment at Thermo Fisher Scientific means going "greener by design." To do so, we’re transitioning to resource-efficient processes, integrating green chemistry practices, and prioritizing circular economy principles to achieve net-zero emissions by 2050. Watch our video from #CPHINorthAmerica featuring Matt Hancock learn more about our company’s approach to #sustainability in #drugdevelopment. As a leading #CDMO, we’re doing our part to create a more eco-friendly future for the #pharmaceutical industry. Watch the full video here: http://spr.ly/6045cONuU
About us
Thermo Fisher Scientific provides industry-leading pharma services for drug development, clinical trial logistics, and commercial manufacturing through our Patheon™ brand. We partner with customers in the pharmaceutical, biotech, and life sciences industries as their trusted CDMO to deliver medicine to patients faster. We believe that doing this successfully not only requires science, technology, and world-class expertise, but also requires a strategic partnership—bonded by key elements such as trust, communication, and collaboration. We embed these elements into every operation, interaction, and step in the drug development journey. With more than 60 locations around the world, we are committed to providing integrated, end-to-end solutions across all phases of development. Our pharma services include API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics services, commercial manufacturing, and packaging. We couple our scientific and technical excellence in these areas with a strategic partnership to provide customers of all sizes access to a global network of facilities and dedicated experts across the Americas, Europe, Asia, and Australia. At Thermo Fisher Scientific, we understand that developing novel therapies and moving them from discovery to patients is a complex, high-risk process. Every customer has different needs, and every newly discovered drug has a unique pathway to reach the market. As a global, full-service CDMO, we help our partners bring innovative molecules and life-changing therapies to market as efficiently and safely as possible.
- Website
-
https://www.patheon.com/us/en/home.html
External link for Patheon
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Waltham, Massachusetts
- Type
- Public Company
- Specialties
- Pharmaceutical Development Services, Biologics, Commercial Manufacturing, API Supply, Softgels, Early Development, and Cell and Gene Therapy
Locations
Updates
-
#Predictivemodeling via #computationalsimulation has the potential to fundamentally change the complex #drugresearch and development process. Our blog takes a look at specific advantages of predictive modeling, breaking down these four benefits for solubility and bioavailability enhancement: - Efficient formulation optimization - Early identification of potential issues - Cost and time savings - Insights into mechanisms and interactions Additionally, it showcases Thermo Fisher Scientific's Quadrant 2™ predictive platform, which can streamline decision-making for pharmaceutical formulators. You can read the full blog here: http://spr.ly/6041igzEd
-
Mastering #technologytransfers is a crucial step to ensure successful #drugproduct market introduction and commercialization. Our comprehensive guide, "9 ways to ensure a successful technology transfer," provides detailed insights into achieving efficient, reliable, and seamless transitions from late-phase to commercial drug manufacturing. Discover how leveraging an integrated network, proactive planning and risk management, and Thermo Fisher Scientific’s #CDMO expertise can streamline the market introduction of your #pharmaceutical. To get the guide, click here: http://spr.ly/6043iLcux
9 ways to ensure a reliable technology transfer
patheon.com
-
Fostering a culture of #knowledgeharing is foundational at Thermo Fisher Scientific, where the open exchange of insights across departments fuels our success as a #CDMO. In our latest #voicesofpartnership video, Emily Anderson and Jessica Floyd reflect on their experiences working in our analytical #researchanddevelopment department. Specifically, they highlight how shared #knowledge and cross-team #collaboration enhance operational flexibility, ensuring vital information reaches clients more quickly. Watch the video to see how our commitment to #knowledgesharing impacts #drugdevelopment, ultimately leading to the delivery of safe and effective medications to patients. See it here: http://spr.ly/6047io0Jf
-
#QualitybyDesign (#QbD) is a systematic approach to #pharmaceuticaldevelopment and manufacturing that emphasizes designing quality into processes from the beginning rather than relying solely on end-product testing. During our recent webinar, Dr. Pouria Motevalian, director of #viralvector process development at Thermo Fisher Scientific, discussed our company’s #QbD approach, featuring a case study from our collaboration with NysnoBio. Learn more here: http://spr.ly/6043i9nCH
Advancing viral vector development through Quality by Design approach
patheon.com
-
One of the highlights of #CPHIMilan 2024 is the opportunity to learn from industry experts in the #biotechnology and #pharmaceutical fields. Thermo Fisher Scientific is excited to participate in this knowledge exchange during two speaking sessions on Tuesday, October 8, 2024: 🔈 Panel discussion: Navigating industry shifts in CDMO-pharma relations - Time: 11:35 a.m. - 12:30 p.m. CEST - Location: Hall 5 Dr. Hrissi Samartzidou, Ph.D. will join this panel discussion on recent developments in the pharmaceutical industry, exploring how they’re driving significant transformation in the CDMO and CRO space. 🔈 Fireside chat: Navigating outsourcing partnerships for start-ups - Time: 13:15 p.m. - 13:30 p.m. CEST - Location: Hall 5 Kelly Howard will join this fireside chat on navigating outsourcing partnerships for start-ups, showcasing best practices for collaborating with external partners to accelerate growth and drive innovation. To learn more about these speaking sessions or schedule a meeting with our team, click here: http://spr.ly/6048imQkm
CPHI Milan 2024
patheon.com
-
In our recent webinar, we explored the complex landscape of #activepharmaceuticalingredient (#API) commercial production, emphasizing its critical role in guaranteeing the quality, efficacy, and safety of pharmaceutical drugs. With a focus on Thermo Fisher Scientific's comprehensive approach, we showcased the indispensable guidance and solutions #CDMOs offer, encompassing #scalability, #sustainability, cost optimization, and manufacturing flexibility. Through case studies, we highlighted strategies for enhancing #commercialproduction processes, from leveraging cutting-edge technologies to ensuring #regulatorycompliance, demonstrating the impact of a strategic #CDMO partnership. Watch the on-demand webinar here: http://spr.ly/6041ilLmL
The road to commercial readiness: Mastering API production at every scale
patheon.com
-
Exciting news from Thermo Fisher Scientific’s site in #Singapore: Our newly expanded operations are up and running with their first #techtransfer. Our local team was selected by a customer in #biopharma to support the development and manufacture of their #liquidvial product used to treat certain #autoimmune diseases and types of #cancer. This work will leverage the offerings of our site expansion, completed last year with assistance from the Singapore Economic Development Board (EDB). We are committed to serving as a reliable partner in the #Asia-Pacific region and globally. As our #biopharma customers work to deliver lifesaving #therapies for patients, they look to #CDMO partners to support them from molecule to market. Our team is there every step of the way — enabling our customers to make the world healthier, cleaner, and safer. To learn more about our #Singapore site, click here: http://spr.ly/6040iZq7C
Singapore Sterile Fill Finish Facility
patheon.com
-
For #biotech and #pharma companies seeking a competitive advantage, embracing a mindset focused on the #patientexperience is becoming a strategic imperative. Learn about four patient-centric trends shaping today’s #biopharma landscape, as detailed in the CPHI trend report, “The nexus between #patient and #bigpharma.” Additionally, explore how third-party vendors like integrated #CROs and #CDMOs can support #drugdevelopers in their efforts to prioritize patient centricity. Learn more here: http://spr.ly/604394ztD
-
Watch our new #voicesofpartnership video, featuring Angie West. Angie, a key player in Thermo Fisher Scientific’s #clinicaltrials division, was tasked with an urgent client request to support a global #clinicaltrial involving 60,000 patients across 35 countries each month. The challenge was intensified by a compressed timeline: A project of that scope would typically take eight weeks, but Angie’s team was only given four. Through coordination, Angie’s team transformed part of their facility into a training lab, ensuring trial operators were well prepared. Additionally, their project managers worked through weekends to maintain momentum. Thanks to these efforts, the team reduced their client’s #clinicaltrial cycle times by 55% and maintained that accelerated pace for 18 months. Learn more here: http://spr.ly/604994JrV